Exodus Point Capital Management, LP Syndax Pharmaceuticals Inc Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
A detailed history of Exodus Point Capital Management, LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 625,723 shares of SNDX stock, worth $11.9 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
625,723
Previous 286,330
118.53%
Holding current value
$11.9 Million
Previous $6.82 Million
88.5%
% of portfolio
0.09%
Previous 0.05%
Shares
10 transactions
Others Institutions Holding SNDX
# of Institutions
201Shares Held
87MCall Options Held
268KPut Options Held
76.8K-
Black Rock Inc. New York, NY7.91MShares$150 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA7.34MShares$139 Million0.03% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.72MShares$108 Million9.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.8MShares$90.9 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.89MShares$73.6 Million1.09% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $1.07B
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...